San Diego-based biotech company Illumina bets on India for growth

While Illumina is reducing its workforce in the US, it plans to hire in India, where it currently employs only 30 people

San Diego-based biotech company Illumina is bolstering its presence in India, anticipating the addressable market in the country for genomic sequencing and testing to almost double from the current levels by 2027.

Speaking to Business Standard, Joydeep Goswami, chief financial officer, and chief strategy and corporate development officer of Illumina, said that as the GDP per capita grows, the spending on healthcare also grows, as people demand better care.

“Our mission is to use genomics for advancement of healthcare. We have been involved in the Genome India Project (that was sequencing genomes from the Indian population); we have been working in the